Targeting methionine metabolism in cancer: opportunities and challenges

Area of Science:

• Oncology
• Metabolic pathways
• Cancer immunology

Background:

• Reprogramming of methionine metabolism is a key feature of cancer development.
• The tumor microenvironment (TME) plays a crucial role in regulating cancer methionine metabolism.
• Altered methionine metabolism impacts both tumor progression and the evasion of antitumor immunity.

Purpose of the Study:

• To review current understanding of how tumors regulate methionine metabolism.
• To summarize emerging therapies targeting tumor methionine metabolism.
• To discuss challenges and future strategies for methionine-based cancer therapies.

Main Methods:

• Literature review of recent advancements in cancer metabolism and immunology.
• Analysis of mechanisms linking methionine metabolism to tumorigenesis and immune evasion.
• Synthesis of information on current and developing therapeutic strategies.

Main Results:

• Tumor cells extensively alter methionine metabolism to support growth and survival.
• Methionine metabolism reprogramming is critical for evading the host immune system.
• Several therapeutic strategies targeting methionine metabolism are under investigation.

Conclusions:

• Targeting tumor methionine metabolism presents a promising avenue for cancer therapy.
• Overcoming challenges in methionine blockade therapies is essential for clinical success.
• Further research into novel strategies is needed to effectively leverage methionine metabolism in cancer treatment.